Quest Pharmatech announces change of chief executive officer
Dr. Madi Madiyalakan will retire as CEO effective Nov. 23, 2026. Jeffrey Shon has been appointed CEO.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Dr. Madi Madiyalakan will retire as CEO effective Nov. 23, 2026. Jeffrey Shon has been appointed CEO.
EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today announces the change of its…